Summary:
In adults diagnosed with chronic high-altitude disease living at high elevation, hydrogen-rich water (HRW) supplementation for 60 days as primary hydration source demonstrated significant downregulation of inflammation- and cytokine-related gene expression pathways with non-significant downward trends in oxidative stress and systemic inflammation markers compared to placebo water without hydrogen enrichment, with no major adverse effects reported.
| PICO | Description |
|---|---|
| Population | Adults diagnosed with chronic high-altitude disease living at high elevation. |
| Intervention | Hydrogen-rich water (HRW) supplementation for 60 days, consumed daily as the primary hydration source. |
| Comparison | Placebo water (PW) without hydrogen enrichment, identical in appearance and consumption pattern. |
| Outcome | HRW significantly downregulated inflammation- and cytokine-related gene expression pathways. Oxidative stress markers showed non-significant downward trends. No major adverse effects. |
Clinical Context
Chronic high-altitude disease (CHAD) affects millions at elevations above 2,500 meters. Molecular hydrogen (H₂) has selective antioxidant properties, and hydrogen-rich water provides practical delivery.
Clinical Pearls
1. Transcriptomic Changes Precede Biomarker Changes: The study found significant gene expression changes even though standard inflammatory biomarkers showed only trends.
2. 60 Days May Be Insufficient: Chronic high-altitude disease develops over years; reversing established pathophysiology likely requires prolonged intervention.
3. Practical Intervention: HRW can be produced with relatively simple technology, making it potentially accessible for high-altitude communities.
4. Safety Profile Favorable: No major adverse effects were reported, consistent with hydrogen’s generally recognized safety.
Practical Application
This study provides preliminary evidence but is insufficient to recommend HRW as established treatment for chronic high-altitude disease. Established approaches remain standard of care.
Study Limitations
Sample size appears small. Sixty-day duration may be insufficient. Transcriptomic changes may not translate to clinical improvement.
Bottom Line
Hydrogen-rich water supplementation for 60 days significantly modulated inflammatory gene expression pathways in chronic high-altitude disease, with trends toward reduced oxidative stress.
Source: “Hydrogen-Rich Water in Chronic High-Altitude Disease: Randomized Controlled Trial.” Read article